Advertisement

Topics

Hugin Group Company Profile

03:52 EST 16th December 2018 | BioPortfolio

Hugin offers communication professionals the most innovative, straight through processing solution for delivery of unedited corporate news to targeted audiences. Hugin's breakthrough technology has transformed this process for hundreds of Europe's leading companies. “Using Hugin’s international press services has proven to be a highly valuable tool for gaining press to our markets outside of Scandinavia. We have accessed numerous channels that we couldn’t have tapped on our own.”

Location

Larsbjørnsstræde 3
Copenhagen K
DK-1454
Denmark

Contact

Phone: 45 70 27 15 44
Fax: 45 33 37 72 13
Email: bo.dungal@hugingroup


News Articles [678 Associated News Articles listed on BioPortfolio]

The reinvention of Bob Hugin: Amid anger over drug prices, a former pharma CEO makes a run for the Senate

Bob Hugin, the former CEO of Celgene, has left behind conference halls and princely pay packages. Now: hot, sweaty campaign events in Jersey.

Bob Hugin concedes defeat in New Jersey — but doesn’t concede his pharma background played a role

Bob Hugin’s former drug company, Celgene, has taken flak for hiking the price of cancer drugs. He says that’s not why he lost his bid for New Jersey Senate.

STAT Plus: Drug industry takes center stage in Senate race, as Hugin punches back against Menendez

Bob Hugin, former Celgene CEO and now a U.S. Senate candidate, tries to turn the table on Bob Menendez over drug prices.

Fact-checking an ad war over drug prices, Celgene, and Bob Hugin

The campaign pitting Sen. Bob Menendez against former Celgene boss Bob Hugin has sparked a series of ads over drug prices. We fact-checked them.

Former Celgene CEO Bob Hugin loses midterm election

Former Celgene CEO Bob Hugin has failed in his bid to win over the people of New Jersey, after voters last night elected Democratic candidate Bob Menendez in the US midterm elections. Despite receivin...

Former Celgene CEO Bob Hugin loses in US midterm elections

Former Celgene CEO Bob Hugin has failed in his bid to win over the people of New Jersey, after voters last night elected Democratic candidate Bob Menendez in the US midterm elections. Despite receivin...

Former Celgene CEO Bob Hugin loses midterm election http://bit.ly/2PcZ5Pj  #Midterms2018 #USmidterms #pharmapic.twitter.com/T5iicgz3uS

Former Celgene CEO Bob Hugin loses midterm election http://bit.ly/2PcZ5Pj  #Midterms2018 #USmidterms #pharma pic.twitter.com/T5iicgz3uS

Former Celgene CEO Bob Hugin loses midterm election http://bit.ly/2PcZ5Pj  #USmidterms #elections #pharma

Former Celgene CEO Bob Hugin loses midterm election http://bit.ly/2PcZ5Pj  #USmidterms #elections #pharma

PubMed Articles [1751 Associated PubMed Articles listed on BioPortfolio]

Does Timing of Surgery Affect Treatment of the Terrible Triad of the Elbow?

BACKGROUND This study investigated the influence of surgical timing on the treatment of terrible triad of the elbow (TTE). MATERIAL AND METHODS After exclusion, 63 patients were enrolled in this study...

Isolation and exploitation of minority: Game theoretical analysis.

We investigate various group-size distributions occurring in a situation where each group's resource is exposed to appropriation by other groups. The amount of appropriation depends on the size differ...

Group I introns are widespread in archaea.

Group I catalytic introns have been found in bacterial, viral, organellar, and some eukaryotic genomes, but not in archaea. All known archaeal introns are bulge-helix-bulge (BHB) introns, with the exc...

The role of group cohesion in a group-based behavioral weight loss intervention.

Behavioral weight loss interventions are often delivered in groups. Group cohesion may enhance program attendance and, thereby, weight loss. In this secondary analysis, our goals were to: (1a) assess ...

Experimental animal study of docetaxel combined with carboplatin in the treatment of retinoblastoma.

The synergistic effects of docetaxel (DTX) combined with carboplatin in the treatment of retinoblastoma (RB) was explored in mouse RB xenografts compared with carboplatin alone and DTX alone groups. R...

Clinical Trials [4119 Associated Clinical Trials listed on BioPortfolio]

The Influence of Hypotensive Drugs on Mineral Status in Experimental and Clinical Studies

The aim of the study was to evaluate the effects of hypotensive treatment combined with a higher zinc supply in the diet and supplements on the mineral status and selected biochemical para...

Safety, Tolerability and Pharmacokinetics of Escalating Single Doses of TAK-828 in Healthy Participants

The purpose of this study is to evaluate the safety and tolerability of single oral doses of TAK-828 in healthy non-Japanese and Japanese participants.

Ultrasound and Exercises in Knee Osteoarthritis

The aim of this investigation is to compare the effects of continuous (CUS) and pulsed (PUS) ultrasound associated with a program of exercises on pain, range of motion, muscle strength, fu...

Technical Development of Multi-Parametric Renocerebral MRI

The purpose of the study is to investigate the associations of the age-related changes in the brain, kidneys and cognitive performance in healthy adults by utilizing multiple anatomic and ...

The T2T Study of RA Based on SSDM

This study evaluate the Smart System of Disease Management(SSDM)to improve the treat-to-target(T2T) and the safety of drug in the treatment of rheumatoid(RA). All participants will be ...

Companies [1642 Associated Companies listed on BioPortfolio]

Hugin Group

Hugin offers communication professionals the most innovative, straight through processing solution for delivery of unedited corporate news to targeted audiences. Hugin's breakthrough technology has tr...

W2 Group, Inc.

W2 Group is a global marketing services ecosystem that helps CMOs in their new role as builders of communities and content aggregators. W2 Group companies, including Digital ...

PharmEvo (Pvt.) Ltd.

PharmEvo is backed by a reputable corporate group with a history of successful business ventures spread over 30 years. The group made its debut in 1971, with the sales and marketing of prestigious bra...

ACE Group

Celebrating 25 years of insuring progress, the ACE Group is a global leader in insurance and reinsurance serving a diverse group of clients. Headed by ACE Limited (NYSE:ACE), a co...

Man Group plc

The Man Group has its origins over 200 years ago in a broking business founded by James Man and was floated on the London Stock Exchange in 1994. Man Group plc trades on the London Stock Exchange (EMG...

More Information about "Hugin Group" on BioPortfolio

We have published hundreds of Hugin Group news stories on BioPortfolio along with dozens of Hugin Group Clinical Trials and PubMed Articles about Hugin Group for you to read. In addition to the medical data, news and clinical trials, BioPortfolio also has a large collection of Hugin Group Companies in our database. You can also find out about relevant Hugin Group Drugs and Medications on this site too.

Advertisement
Quick Search
Advertisement
Advertisement

 

Corporate Database Quicklinks



Searches Linking to this Company Record